financetom
Business
financetom
/
Business
/
L'Oreal misses fourth-quarter expectations with 2.5% rise in sales
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
L'Oreal misses fourth-quarter expectations with 2.5% rise in sales
Feb 6, 2025 9:48 AM

PARIS (Reuters) -French cosmetics group L'Oreal reported a 2.5% rise in fourth-quarter sales on Thursday, missing expectations due to persistently weak demand in China and a slowdown in growth in North America.

The owner of brands from Maybelline mascara to Lancome face cream said sales for the three months to end-December were 11.08 billion euros ($11.49 billion), up 2.5% on a like-for-like basis, versus expectations for a 4.4% rise, according to a consensus compiled by LSEG.

The results, slowing from a 3.4% rise in the third quarter, conclude a challenging year when a protracted slowdown in the Chinese economy and inflation in the United States dented demand for skincare and makeup in two of the company's biggest markets.

Paris-based L'Oreal also lost market share in China's mass market to domestic rivals such as Proya, analysts say, and its CeraVe and other products recommended by dermatologists face growing competition in developed markets.

Sales grew 1.4% in North America, much less than the 5.2% reported in the third quarter. In North Asia, revenues were down by 3.4%, after a 6.5% decline in the prior period.

The company said in October fourth-quarter sales growth would be comparable to the prior quarter's.

($1 = 0.9641 euros)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Vitamin Shoppe's telehealth service to provide access to weight-loss drugs
Vitamin Shoppe's telehealth service to provide access to weight-loss drugs
May 8, 2024
May 8 (Reuters) - Health and wellness products retailer Vitamin Shoppe said on Wednesday that subscribers to its telehealth service would have access to weight-loss medications such as Ozempic, Mounjaro and Rybelsus. Monthly medication subscription to the retailer's virtual healthcare platform, Whole Health Rx, starts at an introductory price of $219, and does not require insurance, the company said in...
AstraZeneca to Reportedly Withdraw COVID-19 Vaccine Amid Cooling Demand
AstraZeneca to Reportedly Withdraw COVID-19 Vaccine Amid Cooling Demand
May 8, 2024
09:04 AM EDT, 05/08/2024 (MT Newswires) -- AstraZeneca ( AZN ) said Tuesday it has started its worldwide withdrawal of its COVID-19 vaccine due to the availability of several vaccines that have led to a drop in demand, according to media reports. Price: 76.56, Change: +0.24, Percent Change: +0.31 ...
Atlantica Sustainable Infrastructure Q1 Net Loss Narrows as Revenue Increases; Maintains Quarterly Dividend
Atlantica Sustainable Infrastructure Q1 Net Loss Narrows as Revenue Increases; Maintains Quarterly Dividend
May 8, 2024
09:06 AM EDT, 05/08/2024 (MT Newswires) -- Atlantica Sustainable Infrastructure ( AY ) reported a Q1 net loss Wednesday of $0.05 per diluted share, narrower than a loss of $0.09 a year earlier. Analysts surveyed by Capital IQ expected a loss of $0.16 per share. Revenue for the quarter ended March 31 was $242.9 million, up from $242.5 million a...
Amerigo Resources Q1 Profit Plunges
Amerigo Resources Q1 Profit Plunges
May 8, 2024
09:06 AM EDT, 05/08/2024 (MT Newswires) -- Amerigo Resources ( ARREF ) reported Wednesday a steep decline in net income for the first quarter. America posted net earnings of US$4.3 million, or US$0.03 per share, during the period, down from US$9.1 million, or US$0.05 per share. Revenue fell to US$44.9 million from US$52.6 million. EBITDA slipped to US$13.6 million from...
Copyright 2023-2026 - www.financetom.com All Rights Reserved